Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2008
12/31/2008EP2007760A1 Novel substituted-1, 1-dioxo-benzo[1,2,4]thiadizin-3-ones, preparation method thereof, and pharmaceutical composition containing the same
12/31/2008EP2007748A2 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/31/2008EP2007747A1 Process for preparing heterocyclic derivatives
12/31/2008EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
12/31/2008EP2007729A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
12/31/2008EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP1546099B1 3,6-disubstituted azabicyclo 3.1.0 hexane derivatives useful as muscarinic receptor antagonists
12/31/2008EP1435785B1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
12/31/2008EP1309587B1 Cinnoline compounds
12/31/2008CN101336239A Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
12/31/2008CN101336235A 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
12/31/2008CN101333196A 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
12/31/2008CN101333192A Biaryl substituted pyrazoles as sodium channel blockers
12/31/2008CN100447140C 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
12/31/2008CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
12/31/2008CA2690378A1 Phthalazine compounds, compositions and methods of use
12/31/2008CA2690176A1 Novel herbicides
12/31/2008CA2686224A1 Piperazine compounds having herbicidal action
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470798 7,8-bicycloalkyl-chroman derivatives
12/30/2008US7470793 Thiazol-(bi)cycloalkyl-carboxanilides
12/30/2008US7470792 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
12/30/2008US7470790 for treatment of various neurodegeneration, including that from stroke, Alzheimer's disease, Parkinson's disease, and Huntington's disease; [6-(1-benzyl-4-hydroxy-pyrrolidin-3-ylmethyl)-pyridin-2-yl]-carbamic acid tert-butyl ester
12/30/2008US7470712 Amino-benzazoles as P2Y1 receptor inhibitors
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470708 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
12/30/2008US7470701 e.g. 3-(4-fluorophenyl)-N-{5-[2-(methylamino)pyrimidin-4-yl]thien-2-yl}propanamide; PKB/Akt kinase inhibitor; anticarcinogenic agent; carcinoma, cancer metastases, squamous cell carcinoma, esophageal squamous cell carcinoma, oral carcinoma, cutaneous T cell lymphoma, Hodgkin's lymphoma
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470699 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis
12/30/2008US7470681 Pyrimidine compounds
12/30/2008CA2441771C Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i
12/30/2008CA2429850C Ep4 receptor selective agonists in the treatment of osteoporosis
12/30/2008CA2356300C 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
12/30/2008CA2312098C A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
12/30/2008CA2245587C Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/25/2008US20080319188 Novel pyridine derivatives and pyrimidine derivatives (3)
12/25/2008US20080319033 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma
12/25/2008US20080319024 Rosiglitazone Phosphate and Polymorphic Forms
12/25/2008US20080319017 Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor Modulators
12/25/2008US20080319011 Protein tyrosine kinase enzyme inhibitors
12/25/2008US20080318984 Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof
12/25/2008US20080318978 Hyperaldosteronism; 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]phyridin-5-yl)cyclohexanecarbonitrile; 1-[3-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-8-yl)pyrrolidin-1-yl]ethanone
12/25/2008US20080318954 Compounds
12/25/2008US20080318944 N-aroyl cyclic amine derivatives as orexin receptor antagonists
12/25/2008US20080318937 Tricyclic delta-opioid modulators
12/25/2008US20080318936 Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines
12/25/2008US20080318933 5-Sulfonyl-1-Piperidinyl Substituted Indole Derivatives as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
12/25/2008US20080318927 Substituted monocyclic CGRP receptor antagonists
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/24/2008WO2008157575A1 Protein kinase inhibitors and methods for using thereof
12/24/2008WO2008157500A1 Aminoquinazoline cannabinoid receptor modulators for treatment of disease
12/24/2008WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia
12/24/2008WO2008157162A1 Dipeptide analogs as coagulation factor inhibitors
12/24/2008WO2008156208A1 5-phenyl-3-pyridazinone derivative
12/24/2008WO2008156174A1 Pyrazinamide compound
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008156092A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008WO2008154817A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
12/24/2008WO2008125839A3 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
12/24/2008WO2008121861A3 Pyrazole and pyrrole compounds useful in treating iron disorders
12/24/2008WO2008057856A3 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
12/24/2008WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
12/24/2008WO2008010089A3 Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof
12/24/2008EP2004641A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
12/24/2008EP2004639A2 Processes for the synthesis of azetidinone
12/24/2008EP2004635A1 Substituted enaminocarbonyl compounds
12/24/2008EP2004632A1 Hiv inhibiting 5-amido substituted pyrimidines
12/24/2008EP2004625A2 C-met protein kinase inhibitors for the treatment of proliferative disorders
12/24/2008EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
12/24/2008EP2003975A1 3-amino-1,2-benzisothiazole compounds for combating animal pest
12/24/2008EP1805169B1 Histamine h3 receptor inhibitors, their preparation and therapeutic uses
12/24/2008EP1554274B1 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/24/2008EP1551804B1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
12/24/2008CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds
12/24/2008CN101328171A Bromophenyl-substituted thiazole dihydropyrimidine
12/24/2008CN101328170A Fluorophenyl-substituted thiazole dihydropyrimidine
12/24/2008CN101328169A Diethylcarbamyl-substituted thiazole dihydropyrimidine
12/24/2008CN101328168A Diethylcarbamyl-substituted thiazole dihydropyrimidine
12/24/2008CN101328163A Compounds, compositions and methods
12/24/2008CN101328150A 新的苯并咪唑衍生物 New benzimidazole derivatives
12/24/2008CN100445274C 2,1,3-benzothiadiazoles for use as electronic active components
12/24/2008CN100445271C Amide derivative
12/24/2008CN100445270C Pyrimidine compounds
12/24/2008CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
12/24/2008CA2692170A1 Azolylmethylidenehydrazine derivative and use thereof
12/24/2008CA2691100A1 Protein kinase inhibitors and methods for using thereof
12/24/2008CA2691056A1 Bromo-phenyl substituted thiazolyl dihydropyrimidines for treating and preventing hepatitis b infections
12/24/2008CA2687255A1 Heteroarylamide pyrimidone derivatives
12/23/2008US7468380 Nitrogen-containing aromatic derivatives
12/23/2008US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
12/23/2008US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression;
12/23/2008CA2560580C Imidazole compounds for inhibition of a.beta.-peptide production and for modulation of the notch signaling pathway
12/23/2008CA2442557C Dihydro-benzo¬b|¬1,4|diazepin-2-one derivatives as mglur2 antagonists ii
12/23/2008CA2424664C Novel non-imidazole compounds
12/18/2008WO2008154642A2 Antibacterial agents
1 ... 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 ... 628